Uncertainties in the initiation of biofilm formation in chronic infections 1
Bacterial infections in the human body are classically divided into acute or chronic 2 infections. This useful clinical classification usually reflects differences in the 3 expression of gene products known as virulence factors as well as in the lifestyle that 4 bacteria causing the infection adopt. Acute infections last a short time and involve 5 single planktonic (free-swimming) bacteria that cause tissue damage through the 6 production of a large amount of virulence factors. They typically cause severe clinical 7 symptoms and can generally be efficiently treated with either one or more antibiotics. In 8 contrast, chronic infections are characteristically associated with bacterial aggregates, 9 commonly referred to as biofilms, where bacteria are physically joined together and 10 encased in a self-produced extracellular matrix made of exopolysaccharides, large 11 surface proteins, fatty acids and DNA. Biofilm-mediated infections persist in spite of 12 antibiotic therapy and the host's innate and adaptive immune responses [1] [2] [3] [4] . Although 13 the biofilm is the predominant mode of growth for bacteria in most natural and clinical 14 environments, some bacterial species are more prone to produce chronic infections, 15 suggesting either that they have a high capacity to reach locations suitable for biofilm 16 settlement or that they possess special skills to efficiently switch from a planktonic to a 17 sessile lifestyle on the surface of inert or living tissues. Despite the wealth of knowledge 18 gained over the years on the biofilm formation process and their implication in chronic 19 infections [5, 6] very little is known about how the biofilm development process starts 20 on the surface of host tissues and how the host cell responds to this process. In this 21 regard, the animal models currently used to examine in vivo biofilm infections, such as 22 device-related endocarditis or placement of a piece of catheter under the skin, provide 23 insights into the factors required for the progression of the infection. However, new 24 methodological strategies, such as direct observation of biofilm development on tissue 25 surfaces and in situ genome-wide transcriptomic profiling, are needed to further explore 1 initial steps governing in vivo biofilm development for the progression of a chronic 2 infection. Significant challenges for the implementation of these methods will be the 3 low number of planktonic bacteria from which biofilm infection is supposed to start and 4 also the short period of time occurring between initial bacterial adhesion and the switch 5 to a sessile lifestyle. Thus, taking into consideration the scarce background information, 6
we first provide a brief overview of the main signal transduction pathway, based on 7 cyclic di-nucleotides (c-di-NMPs) secondary messengers, that governs the initial 8 planktonic-to-biofilm switch and then discuss the emerging information about the role 9 of c-di-NMPs as pathogen-associated molecular patterns (PAMPs) triggering a host 10 innate immune response. Subsequently, we raise the possibility that both processes 11 might be connected during the initial steps of biofilm development that precede the 12 establishment of a chronic infection. 13
14

Switch to biofilm formation and signal transduction 15
A first step to trigger the transition between a motile, single-cell state to an adhesive, 16 multicellular state on the surface of a particular tissue is the recognition and 17 transmission of signals that bacteria use to identify it is appropriate to settle down. 18
Several signals have been shown to favor early settlement of bacteria on human tissues 19 including: (i) the presence of inert surfaces (plastics, metals and devitalized bone); (ii) 20 increased amounts of extracellular iron and ferritin that induce a Pseudomonas 21 aeruginosa biofilm phenotype in sputum of cystic fibrosis patients; (iii) compromised 22 tissues with elevated levels of glucose in diabetic patients; (iv) imbalances in the 23 commensal microbial communities caused by antibiotic treatments, or age-related 24 deterioration; (v) simultaneous or a previous viral infection; (vi) Bacteria have two major sensory systems for the recognition of these signals: two-6 component systems (TCSs) and the c-di-GMP mediated signal transduction network. 7
TCSs are the basic stimulus-response coupling mechanism in bacteria. The best 8 characterized example of a TCS driving the motile/sessile switch is the intricate 9
LadS/RetS/Gac/Rsm signal transduction system of P. aeruginosa, where the 10 GacS/GacA TCS represses the expression of the CsrA homolog RsmA, which 11 reciprocally regulates factors involved in acute infection (motility and the type III 12 secretion system) and chronic infection (exopolysaccharides and the type VI secretion 13 system) (for review see [13, 14] ). However, TCSs are not typically implicated in 14 controlling the switch between planktonic and sessile lifestyles. Instead, they are 15 dedicated to match the production of specific compounds of the biofilm matrix with the 16 environmental conditions. The signal transduction system that has taken on the 17 responsibility to inhibit motility and promote biofilm development in a diverse range of 18 bacterial species is the one that depends on the secondary messenger c-di-GMP. and current methods cannot be applied to measure c-di-GMP during infection. In this 23 regard, the development of a highly sensitive c-di-GMP-dependent reporter system to 24 rapidly monitor the level of the nucleotide in infecting living bacteria would be 25 extremely useful to investigate the role of this signaling pathway during infection. 1
Besides, since only a few c-di-GMP receptors have been identified, the experimental 2 strategy to characterize the role of c-di-GMP has been based on the analysis of bacterial 3 mutants overloaded with or depleted of c-di-GMP. This is in principal a valid approach 4 that has produced many important insights, but a serious problem related with it is that 5 constant high or low levels of c-di-GMP may affect the activity of several c-di-GMP 6 receptors at the same time and thus have an influence on more than one bacterial 7
process. This scenario may not necessarily resemble a real progression in the 8 establishment of a chronic infection. In support of this prediction, the pioneering work 9
of Pultz et al. 
